1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Biopharmaceutical Contract Manufacturing Market – By Product

1.3.2        North America Biopharmaceutical Contract Manufacturing Market – By Service

1.3.3        North America Biopharmaceutical Contract Manufacturing Market – By Source

1.3.4        North America Biopharmaceutical Contract Manufacturing Market – By Country

2.           North America Biopharmaceutical Contract Manufacturing Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Biopharmaceutical Contract Manufacturing – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America – PEST Analysis

4.3         Expert Opinion

5.           North America Biopharmaceuticals Contract Manufacturing Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Outsourcing by Pharmaceutical Companies

5.1.2        Increasing Demand for Biologics

5.2         Market Restraints

5.2.1        Growing Competition in Industry

5.3         Future Trends

5.3.1        Consolidation in Pharmaceutical CMO Industry

5.3.2        COVID-19 Pandemic

5.4         Impact Analysis

6.           Biopharmaceutical Contract Manufacturing Market – North America Analysis

6.1         North America Biopharmaceutical Contract Manufacturing Market Revenue Forecast and Analysis

7.           North America Biopharmaceuticals Contract Manufacturing Market Analysis – By Product

7.1         Overview

7.2         North America Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2021 and 2028)

7.3         Biologics

7.3.1        Overview

7.3.2        Biologics: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1          Monoclonal Antibodies

7.3.2.1.1          Overview

7.3.2.1.2          Monoclonal Antibodies: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2          Recombinant Proteins

7.3.2.2.1          Overview

7.3.2.2.2          Recombinant Proteins: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3          Vaccines

7.3.2.3.1          Overview

7.3.2.3.2          Vaccines: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.4          Others

7.3.2.4.1          Overview

7.3.2.4.2          Others: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Biosimilar

7.4.1        Overview

7.4.2        Biosimilar: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Biopharmaceuticals Contract Manufacturing Market – By Service

8.1         Overview

8.2         North America Biopharmaceuticals Contract Manufacturing Market, by Service, 2021 and 2028 (%)

8.3         Process Development

8.3.1        Overview

8.3.2        Process Development: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.1          Downstream Processing

8.3.2.1.1          Overview

8.3.2.1.2          Downstream Processing: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.2          Upstream Processing

8.3.2.2.1          Overview

8.3.2.2.2          Upstream Processing: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Fill and Finish Operations

8.4.1        Overview

8.4.2        Fill and Finish Operations: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Analytical and QC Studies

8.5.1        Overview

8.5.2        Analytical and QC Studies: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Packaging

8.6.1        Overview

8.6.2        Packaging: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Biopharmaceuticals Contract Manufacturing Market – By Source

9.1         Overview

9.2         North America Biopharmaceuticals Contract Manufacturing Market, by Source, 2021 and 2028 (%)

9.3         Mammalian

9.3.1        Overview

9.3.2        Mammalian: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Microbial/Non-Mammalian-Based Biologics

9.4.1        Overview

9.4.2        Microbial/Non-Mammalian-Based Biologics: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

10.        North America Biopharmaceutical Contract Manufacturing Market – Country Analysis

10.1      North America: Biopharmaceutical Contract Manufacturing Market

10.1.1     Overview

10.1.2     North America: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

10.1.2.1       US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1       US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2       US: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.2.1.2.1     US: Biologics Market, 2019-2028 (USD Million)

10.1.2.1.3       US: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.2.1.3.1     US: Process Development Market, 2019-2028 (USD Million)

10.1.2.1.4       US: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.2.2       Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1       Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2       Canada: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.2.2.2.1     Canada: Biologics Market, 2019-2028 (USD Million)

10.1.2.2.3       Canada: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.2.2.3.1     Canada: Process Development Market, 2019-2028 (USD Million)

10.1.2.2.4       Canada: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.2.3       Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1       Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2       Mexico: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.2.3.2.1     Mexico: Biologics Market, 2019-2028 (USD Million)

10.1.2.3.3       Mexico: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.2.3.3.1     Mexico: Process Development Market, 2019-2028 (USD Million)

10.1.2.3.4       Mexico: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

11.        North America Biopharmaceutical Contract Manufacturing Market – Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Boehringer Ingelheim International GmbH

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      THERMO FISHER SCIENTIFIC INC.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      General Electric Company

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      MERCK KGAA

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Lonza

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Samsung Biologics

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      AbbVie Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      WUXI BIOLOGICS

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Ajinomoto Co. Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Biopharmaceutical Contract Manufacturing Market –Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 3.             US Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 4.             US Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 5.             US Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 6.             US Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 7.             Canada Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 8.             Canada Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 9.             Canada Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 10.          Canada Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 11.          Canada Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 12.          Mexico Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 13.          Mexico Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 14.          Mexico Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 15.          Mexico Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 16.          Mexico Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 17.          Organic Developments Done By Companies

Table 18.          Inorganic Developments Done By Companies

Table 19.          Glossary of Terms, North America Biopharmaceutical Contract Manufacturing Market

LIST OF FIGURES

Figure 1.           North America Biopharmaceutical Contract Manufacturing Market Segmentation

Figure 2.           North America Biopharmaceutical Contract Manufacturing Segmentation, By Country

Figure 3.           North America Biopharmaceutical Contract Manufacturing Market Overview

Figure 4.           Biologics Segment Held Largest Share Of Product In North America Biopharmaceutical Contract Manufacturing Market

Figure 5.           US Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America PEST Analysis

Figure 7.           North America Biopharmaceutical Contract Manufacturing Market Impact Analysis of Drivers and Restraints

Figure 8.           North America Biopharmaceutical Contract Manufacturing Market – Revenue Forecast and Analysis – 2020 - 2028

Figure 9.           North America Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2021 and 2028)

Figure 10.        Biologics: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Monoclonal Antibodies: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028  (US$ Million)

Figure 12.        Recombinant Proteins: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Vaccines: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Others: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Biosimilar: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        North America Biopharmaceuticals Contract Manufacturing Market, by Service, 2021 and 2028 (%)

Figure 17.        Process Development: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028  (US$ Million)

Figure 18.        Downstream Processing: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028  (US$ Million)

Figure 19.        Upstream Processing: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Fill and Finish Operations: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Analytical and QC Studies: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028  (US$ Million)

Figure 22.        Packaging: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028  (US$ Million)

Figure 23.        North America Biopharmaceuticals Contract Manufacturing Market, by Source, 2021 and 2028 (%)

Figure 24.        Mammalian: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Microbial/Non-Mammalian-Based Biologics: North America Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        North America: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2021) (USD Million)

Figure 27.        North America: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

Figure 28.        US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)